Physical Address
304 North Cardinal St.
Dorchester Center, MA 02124
A comprehensive psychiatric evaluation of any patient in the general hospital setting should include close attention to complaints, impairments, and deviations of sexual function. Although on occasion, sexual problems are the primary reason for consultation, more often they may provide important clues about an underlying medical or psychologic condition. Consider the “difficult” patient on obstetrics who repeatedly refuses gynecologic exams, the formerly mild-mannered elderly gentleman who now shouts obscenities and gropes at nurses, or the sexually provocative patient who evokes strong reactions from the medical team. Could the patient on obstetrics have a history of sexual trauma, the elderly man a frontal lobe tumor, or the provocative patient a personality disorder? These are a few of many examples that serve to highlight the role that understanding sexuality plays in caring for patients both compassionately and effectively.
The consulting psychiatrist should also be reminded of the importance that being able to maintain a healthy sexual life holds for many patients, regardless of the reason for hospitalization. Sexuality may take on even greater significance for patients suffering from illness that directly impairs sexual function, because of the difficulties both real and perceived. Psychiatric consultants should be alerted to high rates of sexual problems in patients with chronic diseases (especially cardiovascular disease, cancer, diabetes, neurologic problems, end-stage renal disease, and pain). Many chronic diseases result in depression, which in turn contributes to decreased sexual desire. Moreover, psychological reactions to existing illnesses run the gamut, from fear that sex can kill (post-myocardial infarction) to distress over low sexual self-image (post-disfiguring surgery), to avoidance of sex, to fear of pain during sex, to fear that sexual advances will be rejected, all leading to decreased sexual intimacy.
When offering suggestions for patient management, such as prescribing a new psychotropic medication, care should be taken to minimize or treat sexual side effects as much as is possible. This may also help to improve patient rapport and compliance. In cases where sexual dysfunction appears to have a psychological component, or where longer-term behavioral, psychotherapeutic, or pharmacologic therapy may be warranted, referral for outpatient psychiatric care can be arranged. The consulting psychiatrist may be the first to diagnose a sexual problem and can facilitate the transition from inpatient to outpatient care.
Sexual disorders are extremely common. It has been estimated that 43% of women and 31% of men in the United States suffer from sexual dysfunction. In addition, lack of sexual satisfaction is associated with significant emotional (including depression and marital conflict) and physical (e.g., cardiovascular disease and diabetes mellitus) problems.
Sexual disorders affect individuals across the epidemiologic spectrum. Risk factors include: female gender, older age, and co-existing psychiatric or medical (e.g., cardiovascular) disease. It has been estimated that 10% to 54% of patients do not resume sexual activity after myocardial infarction (MI); 45% to 100% of patients with uremia or who are undergoing hemodialysis experience low sexual desire; and 26% to 50% of patients with untreated depression experience erectile dysfunction (ED).
Among those with obesity and a sedentary lifestyle, weight loss and increased physical activity are associated with improved sexual function. The association between race and sexual dysfunction is more variable. There is a strong association between ED and vascular diseases. In fact, ED may be the presenting symptom of cardiovascular disease. ED may be more frequent among individuals with specific genetic mutations (e.g., polymorphisms in genes for nitric oxide synthase) in molecular pathways responsible for resisting endothelial dysfunction. Sexual trauma for both sexes is associated with long-term negative changes in sexual function. A strong association exists between paraphilic disorders and childhood attention-deficit/hyperactivity disorder (ADHD), substance abuse, major depression or dysthymia, and phobic disorder. The prototypical patient with a paraphilic disorder is young, white, and male. Anxiety, depression, and suicidal thoughts or actions, as well as homosexual or bisexual orientation, are commonly associated gender dysphoria.
The ability to maintain adequate sexual function depends on complex interactions among the brain, peripheral nerves, hormones, and the vascular system. Disease states in these systems are associated with sexual dysfunction. However, no single comprehensive view has been established.
Brain regions involved in sexual arousal include the anterior cingulate gyrus, prefrontal cortex, thalamus, temporo-occipital lobes, hypothalamus, and amygdala. The neurotransmitters dopamine and norepinephrine appear to stimulate sexual function, whereas serotonin may inhibit orgasm. Testosterone, estrogen, progesterone, oxytocin, and melanocortin hormones have a positive effect on sex, but prolactin is an inhibitor.
Recent data suggest a central role for nitric oxide (NO) at the vascular level. In women, NO is thought to control vaginal smooth muscle tone; higher levels of NO are associated with increased vaginal lubrication. In men, NO allows for increased intrapenile blood flow, which facilitates erection. NO acts via the generation of cyclic guanosine monophosphate (cGMP), which has vasodilatory properties. Phosphodiesterase type-5 (PDE-5) inhibitors (the prototype of which is sildenafil) act to inhibit the degradation of cGMP, which prolongs the effects of NO. Cholinergic fibers, prostaglandin E, vasoactive intestinal peptide (VIP), and possibly neuropeptide Y (NPY) and substance P may also improve vasocongestion.
Sexual dysfunction may be best understood by having knowledge of the stages of the normal sexual response; these vary with age and physical status. Medications, diseases, injuries, and psychological conditions can affect the sexual response in any of its component phases, and can lead to different dysfunctional syndromes ( Table 25-1 ). Three major models of the human sexual response have been proposed.
IMPAIRED SEXUAL RESPONSE PHASE | FEMALE | MALE |
---|---|---|
Desire | Female sexual interest/arousal disorder Other specified sexual dysfunction: sexual aversion |
Male hypoactive sexual desire disorder Other specified sexual dysfunction: sexual aversion |
Excitement (arousal, vascular) | Female sexual interest/arousal disorder | Erectile disorder |
Orgasm (muscular) | Female orgasmic disorder | Delayed ejaculation Premature ejaculation |
Sexual pain | Genito-pelvic pain/penetration disorder | Other specified or unspecified sexual dysfunction |
Masters and Johnson developed the first model of the human sexual response, consisting of a linear progression through four distinct phases: (1) excitement (arousal); (2) plateau (maximal arousal before orgasm); (3) orgasm (rhythmic muscular contractions); and (4) resolution (return to baseline). Following resolution, a refractory period exists in men.
Kaplan modified the Masters and Johnson model by introducing a desire stage; this model emphasized the importance of neuropsychological input in the human sexual response. The Kaplan model consisted of three stages: (1) desire; (2) excitement/arousal (including an increase in peripheral blood flow); and (3) orgasm (muscular contraction).
Basson, who recognized the complexity of the female sexual response, more recently proposed a biopsychosocial model of female sexuality that consisted of four overlapping components: (1) biology, (2) psychology, (3) sociocultural factors, and (4) interpersonal relationships. Notably, this conceptualization suggested that women may be receptive to, and satisfied with, sex even in the absence of intrinsic sexual desire if other conditions were met (such as emotional closeness). The fact that physical measurements of female arousal (such as increased vaginal secretions) are poorly correlated with sexual satisfaction lends support for Basson's view.
Aging is associated with changes in the normal human sexual response. Men are slower to achieve erections and require more direct stimulation of the penis to achieve erections. Women have decreased levels of estrogen, which leads to decreased vaginal lubrication and narrowing of the vagina. Testosterone levels in both sexes decline with age, which may result in decreased libido.
The newly revised Diagnostic and Statistical Manual of Mental Disorders, 5th edition (DSM-5) classifies sexual disorders into three major categories. Sexual dysfunction is characterized by a clinically significant disturbance in the ability to respond sexually or to experience sexual pleasure. Paraphilic disorders are characterized by recurrent, intense sexual urges that involve unusual objects or activities and cause personal distress or harm to self or others. Gender dysphoria involves conflict between one's assigned and experienced genders, resulting in personal distress or functional impairment. The DSM-5 has made substantial changes to the classification of sexual disorders, as detailed later in this chapter.
The diagnosis of a sexual problem relies upon a thorough medical and sexual history. Physical examination and laboratory investigations may be crucial to identification of organic causes of sexual dysfunction. Primary psychiatric illness may present with sexual complaints ( Table 25-2 ). However, most sexual disorders have both an organic and a psychological component. Physical disorders, surgical conditions ( Table 25-3 ), medications, and use or abuse of drugs ( Table 25-4 ) can affect sexual function directly or cause secondary psychological reactions that lead to a sexual problem. Psychological factors may predispose, precipitate, or maintain a sexual disorder ( Table 25-5 ).
PSYCHIATRIC DISORDER | SEXUAL COMPLAINT |
---|---|
Depression (major depression or dysthymic disorder) | Low libido, erectile dysfunction |
Bipolar disorder (manic phase) | Increased libido |
Generalized anxiety disorder, panic disorder, post-traumatic stress disorder | Low libido, erectile dysfunction, lack of vaginal lubrication, anorgasmia |
Obsessive–compulsive disorder | Low libido, erectile dysfunction, lack of vaginal lubrication, anorgasmia, “anti-fantasies” focusing on the negative aspects of a partner |
Schizophrenia | Low desire, bizarre sexual desires |
Paraphilic disorder | Deviant sexual arousal |
Gender dysphoria | Dissatisfaction with one's own assigned gender and sexual phenotype, causing distress and/or harm |
Personality disorder (passive–aggressive, obsessive–compulsive, histrionic) | Low libido, erectile dysfunction, premature ejaculation, anorgasmia |
Marital dysfunction/interpersonal problems | Varied |
Fears of intimacy/commitment | Varied, deep intrapsychic issues |
ORGANIC DISORDERS | SEXUAL IMPAIRMENT |
---|---|
Endocrine | |
Hypothyroidism, adrenal dysfunction, hypogonadism, diabetes mellitus | Low libido, (early) erectile dysfunction, decreased vaginal lubrication |
Vascular | |
Hypertension, atherosclerosis, stroke, venous insufficiency, sickle cell disorder | Erectile disorder with intact ejaculation and libido |
Neurologic | |
Spinal cord damage, diabetic neuropathy, herniated lumbar disc, alcoholic neuropathy, multiple sclerosis, temporal lobe epilepsy | Sexual disorder—early sign, low libido (or high libido), erectile dysfunction, impaired orgasm |
Local Genital Disease | |
Male: Priapism, Peyronie's disease, urethritis, prostatitis, hydrocele | Low libido, erectile dysfunction |
Female: Imperforate hymen, vaginitis, pelvic inflammatory disease, endometriosis | Genito-pelvic pain, low libido, decreased arousal |
Systemic Debilitating Disease | |
Renal, pulmonary, or hepatic diseases, advanced malignancies, infections | Low libido, erectile dysfunction, decreased arousal |
Surgical Postoperative States | |
Male: Prostatectomy (radical perineal), abdominal-perineal bowel resection | Erectile dysfunction, no loss of libido, ejaculatory impairment |
Female: Episiotomy, vaginal repair of prolapse, oophorectomy | Genito-pelvic pain, decreased lubrication |
Male and female: Amputation (leg), colostomy, and ileostomy | Mechanical difficulties in sex, low self-image, fear of odor |
DRUG | SEXUAL SIDE EFFECT |
---|---|
Cardiovascular | |
Methyldopa | Low libido, erectile dysfunction, anorgasmia |
Thiazide diuretics | Low libido, erectile dysfunction, decreased lubrication |
Clonidine | Erectile dysfunction, anorgasmia |
Propranolol, metoprolol | Low libido, erectile dysfunction |
Digoxin | Gynecomastia, low libido, erectile dysfunction |
Clofibrate | Low libido, erectile dysfunction |
Psychotropics | |
Sedatives | |
Alcohol | Higher doses cause sexual problems |
Barbiturates | Erectile dysfunction |
Anxiolytics | |
Alprazolam, diazepam | Low libido, delayed ejaculation |
Antipsychotics | |
Thioridazine | Retarded or retrograde ejaculation |
Haloperidol | Low libido, erectile dysfunction, anorgasmia |
Risperidone | Erectile dysfunction |
Antidepressants | |
MAOIs (phenelzine) | Erectile dysfunction, retarded ejaculation, anorgasmia |
TCAs (imipramine) | Low libido, erectile dysfunction, retarded ejaculation |
SSRIs (fluoxetine, sertraline) | Low libido, erectile dysfunction, retarded ejaculation |
Atypical (trazodone) | Priapism, retarded or retrograde ejaculation |
Lithium | Low libido, erectile dysfunction |
Hormones | |
Estrogen | Low libido in men |
Progesterone | Low libido, erectile dysfunction |
Gastrointestinal | |
Cimetidine | Low libido, erectile dysfunction |
Methantheline bromide | Erectile dysfunction |
Opiates | Orgasmic dysfunction |
Anticonvulsants | Low libido, erectile dysfunction, priapism |
Lack of information/experience
Unrealistic expectations
Negative family attitudes to sex
Sexual trauma: rape, incest
Childbirth
Infidelity
Dysfunction in the partner
Interpersonal issues
Family stress
Work stress
Financial problems
Depression
Performance anxiety
Gender dysphoria
The sexual history provides an invaluable opportunity to uncover sexual problems ( Case 1 ). Because patients are often embarrassed to discuss their sexuality with physicians or view sex as outside the realm of medicine, and because physicians are often reluctant to broach the topic of sex for fear of offending their patients, the need to make sexual history-taking a routine part of practice is paramount. Physicians should always attempt to be sensitive and non-judgmental in their interviewing technique, moving from general topics to more specific ones. Questions about sexual function may follow naturally from aspects of the medical history (such as introduction of a new medication, or investigation of a chief complaint that involves a gynecologic or urologic problem).
Ms. K, a 28-year-old administrative assistant without a psychiatric history, was admitted with lower abdominal and pelvic pain of unclear etiology. However, she refused a pelvic exam and pelvic ultrasound, which were deemed essential for her work-up. She threatened to leave against medical advice, and psychiatry was consulted to help elucidate her thought process and capacity to make this decision.
On interview, Ms. K was alert, oriented, lucid, and irritable. She stated, “The doctors have no right to do this to me. It's my body. They should find another way.” Her angry words then gave way to tears and sadness. On taking a social and sexual history, Ms. K revealed that she had dated briefly several men, but her fears of sexual intimacy coupled with her partners' infidelities and physical and verbal abuse usually ended her relationships. Over the course of the interview, Ms. K revealed that she had been sexually molested by her stepfather beginning at the age of 12. She expressed resentment towards her mother, who “knew what was going on but stood by and did nothing.”
After this history was revealed, the goal of the consultant was to gain the patient's trust and give the patient some control over her situation. The consultant took time to explain the importance of the pelvic exam and ultrasound in excluding potentially serious conditions. Eventually, the patient agreed to undergo the exams with the condition that only female providers be present and that a small speculum/ultrasound probe be used. With Ms. K's permission, the consultant brought Ms. K's suggestions to the team, who agreed with this plan. Ms. K underwent the exams uneventfully. Her work-up was unrevealing, and she was deemed medically safe to discharge home. The consultant checked back frequently during Ms. K's hospital stay and helped arrange for outpatient psychiatric care.
Screening questions include: Are you sexually active? If so, with men, women, or both? Is there anything you would like to change about your sex life? Have there been any changes in your sex life? Are you satisfied with your present sex life? To maximize its effectiveness, the sexual history may be tailored to the patient's needs and goals. Physicians should recognize that paraphilics are often secretive about their activities, in part because of legal and societal implications. Patients should be reassured about the confidentiality of their interaction (except in cases where their behavior requires mandatory legal reporting, e.g., as with child abuse).
In taking a sexual history, the consulting psychiatrist should recognize that chronic illness often contributes to sexual dysfunction, whether by direct physical damage or associated psychological effects. Patients with cancer, end-stage renal disease, coronary artery disease, multiple sclerosis, and diabetes are all at increased risk of sexual problems. To explore the role physiologic illness may play in sexual dysfunction, consultants should ask questions about diseases, procedures, and medications that might affect hormone balance, disrupt normal anatomic genitalia, cause CNS dysfunction, damage vascular or peripheral nerve supply to sexual organs, or contribute to pain during sexual activity.
With Internet pornography and “cybersex” activities now available on-demand, anytime, psychiatrists should be aware of increasing patient concerns about “sexual addiction.” The sexual history-taker should feel comfortable exploring, as needed, the role of the Internet in the patient's sexual and non-sexual functioning and the potential for excessive and/or compulsive sexual activities. In fact, a new “hypersexual disorder” was proposed for inclusion in DSM-5, although ultimately not included in the text. Yet, the possibility of impulsive, excessive sexual behavior causing distress to self or others remains. Thus, appropriate screening by a trained clinician is essential. “Hypersexuality” may be a primary problem. However, if behaviors are new or rapidly escalating, an underlying medical or neurological problem should be first excluded, particularly in the inpatient setting.
Though history-taking is often the most important tool in the diagnosis of sexual disorders, the physical examination may reveal a clear medical or surgical basis for sexual dysfunction. Special attention should be paid to the endocrine, neurologic, vascular, urologic, and gynecologic systems. Similarly, laboratory studies may be indicated, depending on the degree to which an organic cause is suspected. There is no “routine sexual panel.”
Screening tests can be guided by the history and physical examination. Tests for systemic illness include: complete blood count (CBC), urinalysis, creatinine, lipid profile, thyroid function studies, and fasting blood sugar (FBS). Endocrine studies (including testosterone, prolactin, luteinizing hormone [LH], and follicular stimulating hormone [FSH]), can be performed to assess low libido and erectile disorder (ED). An estrogen level and microscopic examination of a vaginal smear can be used to assess vaginal dryness. Cervical culture and pap smear can be performed to investigate a diagnosis of dyspareunia. The nocturnal penile tumescence (NPT) test is valuable in the assessment of ED. If NPT occurs regularly (as measured by a RigiScan monitor), problems with erection are unlikely to be organic. Penile plethysmography is used to assess paraphilias by measurement of an individual's sexual arousal in response to visual and auditory stimuli. Genetic or chromosomal testing may be pertinent in the evaluation of gender dysphoria with ambiguous genitalia. For example, heritable disorders of abnormal sexual development (e.g., congenital adrenal hyperplasia, 5-alpha reductase-2 deficiency) are in some cases associated with gender dysphoria later in life.
ED (previously referred to as “male erectile disorder” and colloquially as “impotence”) is defined as the inability of a male to obtain or maintain an erection sufficient to complete sexual activity in more than 75% of sexual encounters. Roughly 20–30 million American men suffer from ED; this symptom accounts for more than 500,000 ambulatory care visits to healthcare professionals annually. A number of risk factors for ED have been identified (see Table 25-6 ). Between 50% and 85% of cases of ED have an organic basis. Primary (life-long) ED occurs in 1% of men under the age of 35 years. Secondary (acquired) ED occurs in 40% of men over the age of 60 years; this figure increases to 73% in men who are over 80 years old. ED may be generalized (i.e., it occurs in all circumstances) or situational (i.e., it is limited to certain types of stimulation, situations, and partners). ED may be a symptom of a generalized vascular disease and should prompt further investigation. Bicycle riding has also been linked to penile numbness (associated with perineal nerve damage) and to ED (due to decreased oxygen pressure in the pudendal arteries), although more research is needed. Depression is a common co-morbidity in patients with ED.
Hypertension
Diabetes mellitus
Smoking
Coronary artery disease
Peripheral vascular disorders
Blood lipid abnormalities
Peyronie's disease
Priapism
Pelvic trauma or surgery
Renal failure and dialysis
Hypogonadism
Alcoholism
Depression
Lack of sexual knowledge
Poor sexual technique
Interpersonal problems
This disorder (previously referred to as “retarded ejaculation”) is defined as a persistent infrequency of, delay in, or absence of ejaculation following normal sexual excitement in at least 75% of sexual encounters. It replaces “male orgasmic disorder,” which was similar but substituted “ejaculation” for “orgasm.” Delayed ejaculation is rare; fewer than 1% of men meet DSM-5 criteria . Risk factors include sexual inexperience and young age (under 35). Delayed ejaculation is usually restricted to failure to reach orgasm during intercourse. Orgasm can usually occur with masturbation and/or from a partner's manual or oral stimulation. The condition must be differentiated from retrograde ejaculation, in which the bladder neck does not close off properly during orgasm, causing semen to spurt backward into the bladder. Delayed ejaculation may also be an unsuspected cause of a couple's infertility problems. The male may not have admitted his lack of ejaculation to his partner.
Become a Clinical Tree membership for Full access and enjoy Unlimited articles
If you are a member. Log in here